0001209191-14-023245.txt : 20140326 0001209191-14-023245.hdr.sgml : 20140326 20140326174704 ACCESSION NUMBER: 0001209191-14-023245 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140326 FILED AS OF DATE: 20140326 DATE AS OF CHANGE: 20140326 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED GENETIC TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001273636 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 593553710 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 11801 RESEARCH DRIVE STREET 2: SUITE D CITY: ALACHUA STATE: FL ZIP: 32615 BUSINESS PHONE: 386-462-2204 MAIL ADDRESS: STREET 1: 11801 RESEARCH DRIVE STREET 2: SUITE D CITY: ALACHUA STATE: FL ZIP: 32615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Koenig Scott CENTRAL INDEX KEY: 0001587514 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36370 FILM NUMBER: 14719633 MAIL ADDRESS: STREET 1: 9640 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2014-03-26 0 0001273636 APPLIED GENETIC TECHNOLOGIES CORP AGTC 0001587514 Koenig Scott C/O APPLIED GENETIC TECHNOLOGIES CORP. 11801 RESEARCH DRIVE, SUITE D ALACHUA FL 32615 1 0 0 0 Common Stock 2228 D Stock Option (Right to Buy) 3.50 2019-09-18 Common Stock 11142 D Stock Option (Right to Buy) 3.50 2022-02-08 Common Stock 285 D Stock Option (Right to Buy) 0.35 2023-01-06 Common Stock 32018 D Stock Option (Right to Buy) 4.90 2023-09-18 Common Stock 14285 D Stock Option (Right to Buy) 12.00 2024-03-26 Common Stock 9375 D Option is fully-vested and is exercisable for shares of common stock at any time until the expiration of the option at the holder's election. Option becomes exercisable in equal monthly installments over four years from the date of grant. Option becomes exercisable in equal yearly installments over three years from the date of grant. /s/ Hemmie Chang, attorney-in-fact for Scott Koenig 2014-03-26 EX-24.3_515850 2 poa.txt POA DOCUMENT POWER OF ATTORNEY KNOW ALL BY THESE PRESENTS, that the undersigned hereby authorizes Hemmie Chang and Robert W. Sweet, Jr., each of Foley Hoag LLP, to execute for and on behalf of the undersigned, in the undersigned's capacity as a director of Applied Genetic Technologies Corporation (the "Company"), a Form ID, Forms 3, 4 and 5, and any amendments thereto, and cause such form(s) to be filed with the United States Securities and Exchange Commission pursuant to Section 16(a) of the Securities Act of 1934, relating to the undersigned's beneficial ownership of securities in the Company. The undersigned hereby grants to the attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do personally present, with full power of substitution, resubstitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney's-in-fact substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of, and transactions in, securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 12th day of January, 2014. /s/ Scott Koenig Scott Koenig, M.D., Ph.D.